MediciNova Newsroom

D. Boral Capital Maintains Buy on MediciNova, Maintains $9 Price Target

BenzingaMar 14 07:38 ET

MediciNova Analyst Ratings

BenzingaFeb 21 07:26 ET

D. Boral Capital Initiates MediciNova(MNOV.US) With Buy Rating, Announces Target Price $9

Moomoo NewsDec 2, 2024 08:32 ET

MediciNova Analyst Ratings

BenzingaDec 2, 2024 08:31 ET

D. Boral Capital Initiates Coverage On MediciNova With Buy Rating, Announces Price Target of $9

BenzingaDec 2, 2024 08:31 ET

Analysts Offer Insights on Healthcare Companies: Medicinova (MNOV), Acasti Pharma (ACST) and Avidity Biosciences (RNA)

TipRanksDec 15, 2022 09:50 ET